Box plots of the three-dimensional displacement variations and the COR. حسب Yifei Li (198040)

The basic characteristics of the included studies. حسب Junyin Pan (20700411)

الموضوعات:

Common definitions and criteria for metabolic syndrome. حسب Junyin Pan (20700411)

الموضوعات:

Assessment of study bias in the included research. حسب Junyin Pan (20700411)

الموضوعات:

Results of the effect of dietary anthocyanins on health outcomes, including effect size and heterogeneity analysis. حسب Junyin Pan (20700411)

الموضوعات:

Risk of bias assessment for eligible randomized controlled trials. حسب Junyin Pan (20700411)

الموضوعات:

Summary of studies identified in the literature search, including studies excluded from the analysis and reasons for exclusion. حسب Junyin Pan (20700411)

الموضوعات:

The flow chart of study selection process. حسب Junyin Pan (20700411)

الموضوعات:

Data extracted from included studies for the systematic review and meta-analysis. حسب Junyin Pan (20700411)

الموضوعات:

Specifications and outcomes of clinical trial studies included in the meta-analysis. حسب Junyin Pan (20700411)

الموضوعات:

Comparison of TNF- حسب Mahshid Vafajoo (21144147)

Table 1_The impact of IL-17A inhibitors on scalp and gut microbiota in psoriasis.docx حسب Wenxia Huang (12290795)

"…Moreover, the abundance of Roseburia, Megamonas, and the phylum Bacteroidota increased, although the Firmicutes/Bacteroidota (F/B) ratio showed no significant change. Conclusion: IL-17A inhibitor therapy has the potential to improve the structure and diversity of the scalp microbiome, gradually restoring it toward a healthier state while also enhancing gut microbiota diversity. …"

Data Sheet 1_Unveiling frailty: comprehensive and sex-specific characterization in prematurely aging PolgA mice.pdf حسب Dilara Yılmaz (19710658)

"…We demonstrated that frailty became evident in PolgA mice around 40 weeks, validated through body weight loss, reduced walking speed, decreased physical activity, and weaker grip strength. …"

Image 1_CHMP4A in hepatocellular carcinoma: exploring its role in tumor progression, immune modulation, and potential link to TIM3 checkpoint.pdf حسب Kai Sun (140584)

"…Background<p>Charged Multivesicular Body Protein 4A (CHMP4A), a member of the ESCRT-III family, plays a pivotal role in membrane remodeling and fission, with emerging evidence underscoring its significance in cancer immunotherapy. …"

Table 1_CHMP4A in hepatocellular carcinoma: exploring its role in tumor progression, immune modulation, and potential link to TIM3 checkpoint.docx حسب Kai Sun (140584)

"…Background<p>Charged Multivesicular Body Protein 4A (CHMP4A), a member of the ESCRT-III family, plays a pivotal role in membrane remodeling and fission, with emerging evidence underscoring its significance in cancer immunotherapy. …"

Table 2_CHMP4A in hepatocellular carcinoma: exploring its role in tumor progression, immune modulation, and potential link to TIM3 checkpoint.docx حسب Kai Sun (140584)

"…Background<p>Charged Multivesicular Body Protein 4A (CHMP4A), a member of the ESCRT-III family, plays a pivotal role in membrane remodeling and fission, with emerging evidence underscoring its significance in cancer immunotherapy. …"

Image 2_CHMP4A in hepatocellular carcinoma: exploring its role in tumor progression, immune modulation, and potential link to TIM3 checkpoint.pdf حسب Kai Sun (140584)

"…Background<p>Charged Multivesicular Body Protein 4A (CHMP4A), a member of the ESCRT-III family, plays a pivotal role in membrane remodeling and fission, with emerging evidence underscoring its significance in cancer immunotherapy. …"

Data Sheet 1_CHMP4A in hepatocellular carcinoma: exploring its role in tumor progression, immune modulation, and potential link to TIM3 checkpoint.docx حسب Kai Sun (140584)

"…Background<p>Charged Multivesicular Body Protein 4A (CHMP4A), a member of the ESCRT-III family, plays a pivotal role in membrane remodeling and fission, with emerging evidence underscoring its significance in cancer immunotherapy. …"

Table 1_Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center.docx حسب Naama Lax (20998004)

"…TMA event-free status was reached in 15 (63%) patients. Significant improvements were observed in platelet count (63%), lactate dehydrogenase levels (76% within the first week), hemoglobin (60%), and estimated glomerular filtration rate (79%); while CH-50 levels decreased. …"

Data Sheet 1_Genetic knockdown of DYRK1A attenuates cognitive impairment, Aβ pathology, tauopathy and neuroinflammatory responses in mouse models of AD.docx حسب Hyun-ju Lee (7550741)

"…Conversely, in amyloid-beta (Aβ)-overexpressing 5xFAD mice, hippocampal DYRK1A knockdown improved short-term spatial/recognition memory and significantly increased CaMKIIα and CREB phosphorylation. …"